These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1554491)

  • 1. Induction of polyclonal antibodies to the S1 subunit of pertussis toxin by synthetic peptides coupled to PPD: effect of conjugation method, adjuvant, priming and animal species.
    Ibsen PH; Holm A; Raaschou-Nielsen M; Petersen JW; Capiau C; Heron I
    APMIS; 1992 Feb; 100(2):159-69. PubMed ID: 1554491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of B-cell epitopes on the S4 subunit of pertussis toxin.
    Ibsen PH; Holm A; Petersen JW; Olsen CE; Heron I
    Infect Immun; 1993 Jun; 61(6):2408-18. PubMed ID: 7684728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1347-51. PubMed ID: 2304902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.
    Lussow AR; Del Giudice G; Rénia L; Mazier D; Verhave JP; Verdini AS; Pessi A; Louis JA; Lambert PH
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2960-4. PubMed ID: 2183219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.
    Chong P; Zobrist G; Sia C; Loosmore S; Klein M
    Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animals.
    Lachmann PJ; Strangeways L; Vyakarnam A; Evan G
    Ciba Found Symp; 1986; 119():25-57. PubMed ID: 3015516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of pertussis toxin by antibodies to synthetic peptides.
    Seabrook RN; Robinson A; Sharma RP; Irons LI; Ashworth LA; Price CP; Atkinson T
    Mol Immunol; 1990 Aug; 27(8):777-85. PubMed ID: 2402246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections.
    Raupach B; Schmidt MA
    Microb Pathog; 1994 Oct; 17(4):213-26. PubMed ID: 7536288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the antigenic structure of two cross-reacting proteins, pertussis and cholera toxins, using synthetic peptides.
    Presentini R; Perin F; Ancilli G; Nucci D; Bartoloni A; Rappuoli R; Antoni G
    Mol Immunol; 1989 Jan; 26(1):95-100. PubMed ID: 2927400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
    Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
    Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.
    Roberts M; Bacon A; Rappuoli R; Pizza M; Cropley I; Douce G; Dougan G; Marinaro M; McGhee J; Chatfield S
    Infect Immun; 1995 Jun; 63(6):2100-8. PubMed ID: 7768587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of polyclonal and monoclonal antibody responses to cholera toxin by the synthetic peptide approach.
    Ghose AC; Karush F
    Mol Immunol; 1988 Mar; 25(3):223-30. PubMed ID: 3374493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.
    Chong P; Sydor M; Wu E; Zobrist G; Boux H; Klein M
    Mol Immunol; 1991 Mar; 28(3):239-45. PubMed ID: 2017195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial heat-shock proteins as carrier molecules.
    Lussow AR; Barrios C; van Embden J; Van der Zee R; Verdini AS; Pessi A; Louis JA; Lambert PH; Del Giudice G
    Eur J Immunol; 1991 Oct; 21(10):2297-302. PubMed ID: 1680693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates.
    Peeters JM; Hazendonk TG; Beuvery EC; Tesser GI
    J Immunol Methods; 1989 Jun; 120(1):133-43. PubMed ID: 2499636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
    J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
    Rubinstein A; Goldstein H; Pettoello-Mantovani M; Mizrachi Y; Bloom BR; Furer E; Althaus B; Que JU; Hasler T; Cryz SJ
    AIDS; 1995 Mar; 9(3):243-51. PubMed ID: 7755912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.